CRISPR News and Research

RSS

In the late 1980s and mid-1990s, genomes of diverse lineages of bacteria and archaea (the latter representing a domain of single-celled prokaryotic microorganisms) revealed clusters of regularly interspaced short palindromic repeats, known today under the abbreviation CRISPR. Later it was found that these repeat sequences (previously considered disparate) share a common set of features.

Defense mechanisms of horticulture crops against fungal infections

Recent research on defense responses of horticulture crops to fungal infections, novel ways to govern the induction of plant resistance, issues, challenges, and future research objectives have been summarized by scientists from the Chinese Academy of Sciences.

22 Aug 2022

Researchers determine a novel antiviral technique to combat bacteria

Bacteria use a wide range of defense strategies to combat viral infection, and some of these systems have resulted in game-changing technologies like CRISPR-based gene editing.

From Massachusetts Institute of Technology (MIT) 15 Aug 2022

Study provides guidelines on how to design safer CRISPR reagents

The 2020 Nobel Prize in Chemistry was awarded to Jennifer A. Doudna and Emmanuelle Charpentier for developing the widely utilized and incredibly precise genome editing method known as CRISPR/Cas9

11 Aug 2022

A Retro-Cascorder device records a cell’s genetic activity in DNA for days at a time

If you want to keep track of someone’s activities for a day, contact them every 10 minutes and inquire what they are up to. It would be simpler, though, to equip them with a journal in which to record their own acts.

1 Aug 2022

Novel molecule probe accomplishes live B cells distinction over T cells

The human body is regularly exposed to bacteria, parasites, viruses, and other pathogens, making the immune system vital for survival.

25 Jul 2022

Scientists discover gene editing could potentially enhance wheat grain yield

Scientists have discovered that gene editing of the transcription factor DUO1 can massively improve wheat grain yield.

22 Jul 2022

Research finds mechanism triggering flowering plants to produce fruits and seeds

Food production has grown more and more challenging for producers throughout the globe due to rising global temperatures and declining pollinator populations.

14 Jul 2022

Rice University bioscientists use CRISPR to activate “silent” bacterium genes

In the quest for antibiotics to address the increasing issue of resistance in disease treatment, silence may be the best policy.

14 Jul 2022

NSU explore harmful algae blooms to better understand their origins and management

They are bluish-green, stinky and yucky. We're talking algae blooms, that phenomenon that happens in waterways around Florida. And since 2019, researchers at Nova Southeastern University's (NSU) Halmos College of Arts and Sciences have been studying them with the primary goal to find out why they occur.

13 Jul 2022

Challenges in Drug Discovery; Where are we now, and where are we going?

As part of our SLAS Europe 2022 coverage, we speak to Steve Rees, Vice-President of Discovery Biology at AstraZeneca, about the challenges currently faced by the drug discovery sector.

From Society for Laboratory Automation and Screening (SLAS) 8 Jul 2022

Study highlights retrotransposition in CRISPR gene therapy clinical trials

Worldwide clinical studies for gene therapy utilizing CRISPR/Cas9 gene editing are now underway for a number of disorders. A study from Boston Children’s Hospital that was released in Nature Communications on June 27th, 2022, alerts readers to a possible CRISPR editing risk that has not yet been identified.

8 Jul 2022

How Important is the European Ecosystem to Life Sciences Research?

As part of our SLAS Europe 2022 coverage, we speak to Jan Lichtenberg, vice president of SLAS, about the role Europe plays within life sciences research.

From Society for Laboratory Automation and Screening (SLAS) 7 Jul 2022

Scientists link the function of specific domain of proteins to a cancer trigger in humans

Researchers at the Department of Energy's Oak Ridge National Laboratory have definitively linked the function of a specific domain of proteins important in plant-microbe biology to a cancer trigger in humans, knowledge that had eluded scientists for decades.

6 Jul 2022

Researchers discover a safe strategy to correct genetic defects

Healing debilitating genetic diseases is one of modern medicine’s most difficult challenges.

5 Jul 2022

Experts build artificial Hox genes using new synthetic DNA technology

Using cutting-edge synthetic DNA technology and genomic engineering in stem cells, scientists at New York University have created artificial Hox genes, which regulate and direct where cells go to develop tissues or organs.

From New York University (NYU) 4 Jul 2022

Crucial gene in maize modulates specific chemical processes that contribute to flowering time, study finds

North Carolina State University researchers revealed that a crucial gene in maize called HPC1 modulates some chemical processes that contribute to flowering time.

4 Jul 2022

Researchers understand the processes that affect the efficiency of the CRISPR method

When it comes to the ability of genetic engineering, the only restriction is the human imagination, particularly since the discovery of CRISPR technology.

1 Jul 2022

New study gauges public acceptance of gene-edited foods

Through CRISPR and other gene-editing technologies, researchers and developers are poised to bring dozens – if not hundreds – of new products to grocery stores: mushrooms with longer shelf lives, drought-resistant corn and bananas impervious to a fungus threatening the global supply.

29 Jun 2022

Lipid nanoparticles successfully stopped the emergence and development of tumors cells, a new study reveals

UT Southwestern researchers have developed nanoparticles that can penetrate the physical barriers that surround tumors and reach cancer cells.

27 Jun 2022

Scientists discover proteins that may improve CAR-T cell therapy for solid tumor model

The potential of CAR T-cell therapy for the treatment of solid tumors was unlocked in a preclinical trial by researchers at St. Jude Children’s Research Hospital who discovered a molecular mechanism. The findings were released in the journal Nature.